Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Blanck

Showing results (11-20 of 15) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 15 results.
Journal of Medical Genetics|July 25, 2000
Clinical and molecular cytogenetic studies of a large de novo interstitial deletion 16q11.2-16q21 including the putative transcription factor gene SALL1H Knoblauch, G Thiel, S Tinschert, et al.
Journal of Medical Genetics|May 20, 2000
Three novel SALL1 mutations extend the mutational spectrum in Townes-Brocks syndromeC Blanck, J Kohlhase, S Engels, et al.
Journal of Thrombosis and Thrombolysis|December 30, 1999
High platelet count in platelet-rich plasma reduces measured platelet inhibition by abciximab but not tirofiban nor eptifibatide glycoprotein IIb/IIIa receptor antagonistsD J Kereiakes, T M Broderick, E M Roth, et al.
International Journal of Pharmaceutics|June 28, 2015
Microfluidic conceived Trojan microcarriers for oral delivery of nanoparticlesIkram Ullah Khan, Christophe A Serra, Nicolas Anton, et al.
American Journal of Human Genetics|February 11, 1999
Molecular analysis of SALL1 mutations in Townes-Brocks syndromeJ Kohlhase, P E Taschner, P Burfeind, et al.
Pageof 2

Showing results (11-20 of 15) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 15 results.
Journal of Medical Genetics|July 25, 2000
Clinical and molecular cytogenetic studies of a large de novo interstitial deletion 16q11.2-16q21 including the putative transcription factor gene SALL1H Knoblauch, G Thiel, S Tinschert, et al.
Journal of Medical Genetics|May 20, 2000
Three novel SALL1 mutations extend the mutational spectrum in Townes-Brocks syndromeC Blanck, J Kohlhase, S Engels, et al.
Journal of Thrombosis and Thrombolysis|December 30, 1999
High platelet count in platelet-rich plasma reduces measured platelet inhibition by abciximab but not tirofiban nor eptifibatide glycoprotein IIb/IIIa receptor antagonistsD J Kereiakes, T M Broderick, E M Roth, et al.
International Journal of Pharmaceutics|June 28, 2015
Microfluidic conceived Trojan microcarriers for oral delivery of nanoparticlesIkram Ullah Khan, Christophe A Serra, Nicolas Anton, et al.
American Journal of Human Genetics|February 11, 1999
Molecular analysis of SALL1 mutations in Townes-Brocks syndromeJ Kohlhase, P E Taschner, P Burfeind, et al.
Pageof 2